Jonathan Wesley Riess was named medical director of UC Davis Comprehensive Cancer Center’s Thoracic Oncology Program, replacing David R. Gandara, who will soon be co-directing a new center in experimental cancer therapeutics. Riess’ appointment is effective immediately.
Riess’ clinical interests include lung cancer and other thoracic cancers (mesothelioma and thymoma). He currently serves on the Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel for the National Comprehensive Cancer Network.
Riess’ research interests encompass novel diagnostics, targeted therapies, and immunotherapy in lung cancer and other thoracic malignancies.
Riess is the past recipient of the NCI Cancer Clinical Investigator Team Leadership Award. He is also the past recipient of the Addario Lung Cancer Foundation and Van Auken Foundation Young Innovators Team Award and is a former Paul Calabresi K12 Scholar. Riess was recently awarded an NCI R01 grant for an NCI-sponsored clinical trial.
